Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma

BACKGROUND: Although sorafenib is accepted as the standard of care in advanced hepatocellular carcinoma (HCC), its therapeutic benefit is marginal. Here, we aimed to compare the efficacy and safety of sorafenib monotherapy (S-M) and sorafenib-based loco-regional treatments (S-LRTs) in advanced HCC....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lee, Sangheun, Kim, Beom Kyung, Kim, Seung Up, Park, Yehyun, Chang, Sooyun, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Chon, Chae Yoon, Han, Kwang-Hyub
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2013
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3796498/
https://ncbi.nlm.nih.gov/pubmed/24155932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0077240
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items